MedPath

DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN

Histiacil NF Pentrexicilina NF Brosolvan

Approved
Approval ID

826c2f47-00a6-4060-a7ad-1ef26ccfddd1

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 15, 2025

Manufacturers
FDA

OPMX LLC

DUNS: 029918743

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69729-062
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (11)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
DEXTROMETHORPHAN HYDROBROMIDEActive
Quantity: 20 mg in 5 mL
Code: 9D2RTI9KYH
Classification: ACTIB
GUAIFENESINActive
Quantity: 300 mg in 5 mL
Code: 495W7451VQ
Classification: ACTIB

DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69729-040
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (11)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
DEXTROMETHORPHAN HYDROBROMIDEActive
Quantity: 20 mg in 5 mL
Code: 9D2RTI9KYH
Classification: ACTIB
GUAIFENESINActive
Quantity: 300 mg in 5 mL
Code: 495W7451VQ
Classification: ACTIB

DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69729-020
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (11)

SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
DEXTROMETHORPHAN HYDROBROMIDEActive
Quantity: 20 mg in 5 mL
Code: 9D2RTI9KYH
Classification: ACTIB
GUAIFENESINActive
Quantity: 300 mg in 5 mL
Code: 495W7451VQ
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 3/18/2025

PRINCIPAL DISPLAY PANEL HISTIACIL ADULT

![HISTIACIL ADULT](/dailymed/image.cfm?name=-Histiacil+AD+4+fl+oz+%28RTE%29+EN- ES+Rev+11.2024++%28AKRON%29_001.jpg&id=875354)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 7/13/2022

Uses

  • temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
  • helps to loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 7/13/2022

Questions or comments?
** Call 619-600-5632**

Tamper evident: Do not use if inner seal under cap is broken or missing.

Exclusively distributed by
OPMX
Chula Vista, CA91910
Phone: 619-600-5632

Manufactured in
FDA Registered Facility
In the USA

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 7/13/2022

Inactive ingredients

citric acid, flavor, glycerin, menthol, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium saccharin, sorbitol.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 7/14/2022

Active Ingredient (in each 5 mL) Purpose

Dextromethorphan HBr USP 20 mg............. Cough suppressant

Guaifenesin, USP 300 mg............................... Expectorant

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 7/13/2022

Relieves:
• Chest congestion / Mucus
• Cough

WARNINGS SECTION

LOINC: 34071-1Updated: 7/13/2022

Warnings

*Do not useif you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • cough that occurs with too much phlegm (mucus)
  • cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 7/13/2022

Stop use and ask a doctor ifcough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 7/13/2022

If pregnant or breast-feedingask a health professional before use.

**Keep out of reach of children.**In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 7/13/2022

Directions

  • do not take more than 6 doses in any 24-hour period
  • measure only with dosing cup provided
  • ml=milliliter
  • this adult product is not intended for use in children under 12 years of age

Age

Dose

Adults and children 12 years and over

5 mL every 4 hours

Children under 12 years

do not use

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 7/13/2022

Other information

  • Store at 20°-25°C (68° -77°F).
  • Do not refrigerate.
  • Retain carton for future reference on full labeling

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN - FDA Drug Approval Details